Robak, T.; Iskierka-Jażdżewska, E.; Puła, A.; Robak, P.; Puła, B.
The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs. J. Clin. Med. 2025, 14, 8247.
https://doi.org/10.3390/jcm14228247
AMA Style
Robak T, Iskierka-Jażdżewska E, Puła A, Robak P, Puła B.
The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs. Journal of Clinical Medicine. 2025; 14(22):8247.
https://doi.org/10.3390/jcm14228247
Chicago/Turabian Style
Robak, Tadeusz, Elżbieta Iskierka-Jażdżewska, Anna Puła, Pawel Robak, and Bartosz Puła.
2025. "The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs" Journal of Clinical Medicine 14, no. 22: 8247.
https://doi.org/10.3390/jcm14228247
APA Style
Robak, T., Iskierka-Jażdżewska, E., Puła, A., Robak, P., & Puła, B.
(2025). The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs. Journal of Clinical Medicine, 14(22), 8247.
https://doi.org/10.3390/jcm14228247